Navigating Uncertainty: A Case Study of Intrahepatic Cholestasis of Pregnancy.
Julie Blumenfeld, Kristin Koo
PMID 35373493WHAT IT FOUND
Nighttime itching and rising bile acids in a pregnant patient with prior ICP led to diagnosis, ursodiol, induction at 36 weeks, and a vigorous newborn.
This describes care, not proof that treatment works.
Key findings
01Worsening itching at 35 weeks and 2 days led to repeat labs showing ALT 104 U/L and AST 63 U/L, and later total bile acids 79 μmol/L confirmed ICP.
02The care team recommended ursodiol 300 mg orally twice daily and immediate induction because bile acids were greater than 40 μmol/L and pruritus was unremitting.
03The patient gave birth to a vigorous female newborn with Apgar scores of 8 and 9, and her itching rapidly dissipated over the first 48 hours postpartum.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The case is a composite of elements from different patients. There is no comparison group, so it cannot show whether ursodiol, induction, or other care caused the outcome. The patient received ursodiol, antenatal corticosteroids, cervical ripening, and Pitocin together, so the contribution of any single component cannot be separated. The article notes that bile acid results may take 4 to 14 days, and normal AST and ALT do not exclude ICP. The article also notes that evidence for ursodiol improving fetal outcomes is lacking and that guidelines are not fully consistent. The patient faced Medicaid and immigration barriers to medication cost, so this course may not apply to patients with different access.
Declared interests
The authors declared no conflicts of interest.
The easy way to misread this
Do not read the good newborn outcome as proof that ursodiol or immediate induction prevents fetal death. This is a composite case with multiple simultaneous treatments, and the article states that ursodiol has not been shown to significantly improve fetal outcomes.